MetLife Investment Management, LLC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in AKBA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$128,255
-$73,769 QoQ
Shares Held
92,270
-26.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,279,982 across 37 Drug Manufacturers - Specialty & Generic names. AKBA ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in AKBA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $128,255 | 92,270 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $202,024 | 125,481 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $368,975 | 135,156 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $545,301 | 149,808 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $226,874 | 118,164 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $197,657 | 104,030 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $89,844 | 68,064 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $55,240 | 54,157 | Shares | Defined | 2024-08-13 | |
| 2022-03-31 | $61,163 | 85,186 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $69,601 | 30,797 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $183,530 | 63,726 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $123,102 | 32,481 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $206,132 | 60,896 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $89,868 | 32,096 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $71,025 | 28,297 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $790,043 | 58,177 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $395,873 | 52,226 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||